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Abstract 
BACKGROUND: Association of asthma and obesity has been demonstrated in numerous epidemiological 
studies. However, the underlying mechanisms of the association are not well understood. Both conditions are 
characterised by chronic tissue inflammation, which includes numerous different inflammatory markers, and 
possible atopy. 
AIM: The study aimed to investigate the association between asthma and obesity in children and assess several 
of potential underlying mechanisms, including the parameters of systemic inflammation (CRP, fibrinogen) and the 
mechanical effect of obesity on the respiratory system through parameters of lung function. An additional aim was 
to examine the role of atopy in overweight children with asthma and to investigate the type of respiratory 
inflammation. 
MATERIAL AND METHODS: This prospective study included 72 patients in the age group of 7-15 years, 
including 38 with high body mass index (BMI), 16 with asthma and normal BMI, and 18 with asthma and high BMI 
for sex and age. Non-specific inflammatory markers (fibrinogen, CRP), eosinophilia, and total serum IgE were 
investigated. The patients underwent a skin prick test (SPT) with standard inhalant allergen extracts, 
measurement of fractional exhaled nitric oxide Fe (NO), and an assessment of lung function.  
RESULTS: In overweight groups of children we determined significantly higher values (p < 0.001) of both acute 
inflammatory reactants, CRP and fibrinogen, with no difference between children with and without asthma. There 
was a significant increase in eosinophilia, total IgE, and positive SPT in the asthmatic groups compared to the 
group of non-asthmatic patients (p < 0.001 for the three parameters). Compared to the group composed of 
overweight patients without asthma, the asthmatic patients had higher NO values (p < 0.001). No significant 
difference in the lung function parameters was found between the three groups (p > 0.05). 
CONCLUSION: A positive association between asthma and obesity with inflammation as an underlying 
mechanism, eosinophilic one in asthmatic patients and non-eosinophilic one in overweight patients, was 
determined. It seems that the lung function parameters did not differ between asthmatic patients and overweight 
patients. No influence of atopy in the association between asthma and obesity was verified. Further analyses of 
specific inflammatory markers, for an in-depth evaluation of the mechanisms leading to the association of obesity 
and asthma, are warranted. 
 
 
 
 
 
 
 
 
Introduction 
 
Recently, a parallel epidemic increase in the 
prevalence of asthma and obesity in children has 
been observed. With more than 334 million patients 
worldwide, asthma is considered one of the most 
common chronic diseases. The International Study of 
Asthma and Allergies in Childhood (ISAAC) has found 
a wide variation in the prevalence of asthma in 
childhood [1]. Within this study, in the period between 
2002-2004, a moderate low prevalence of asthma has 
been reported in the Republic of Macedonia that was 
due, at least partially, to under-diagnosis [2]. The 
increasing trend in the prevalence of asthma in both 
adults and children in the last decade has reached a 
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plateau in developed countries. However, the rise of 
obesity prevalence has been established recently in 
developing countries, including Macedonia [3]. 
Worldwide obesity has been nearly tripled since 1975 
as a consequence of changes in diet and the 
decrease in overall physical activity. Obesity has 
become a major public health problem, especially in 
developed countries with more than 1.9 billion 
overweight people, 600 million of which were obese 
[4]. Within ISAAC, a moderately low prevalence of 
overweight children and the low prevalence of obese 
children have been reported in the Republic of 
Macedonia [5]. However, thirteen years later, in a new 
epidemiological study, a significant increasing trend in 
the prevalence of overweight/obese children has been 
identified [6]. 
The relationship between asthma and obesity 
has been demonstrated in numerous epidemiological 
studies, but underlying mechanisms of this 
association are not well understood. Obesity 
increases the prevalence of asthma and asthma-like 
symptoms, compromises the control of the disease, 
decreases the response to anti-inflammatory therapy, 
and impairs the quality of life in patients with asthma. 
The physical or mechanical effect of the adipose 
tissue on the respiratory system is manifested by a 
reduction in pulmonary volumes and respiratory 
compliance [7]. On the other hand, the mechanical 
effect of obesity upon the respiratory system can 
affect the contractile power of the smooth muscle of 
the bronchial trunk inducing bronchial hyperreactivity 
[8].
 
Both conditions are characterised by chronic 
tissue inflammation, which includes numerous, 
although different inflammatory markers which may 
increase the bronchial hyperreactivity in patients with 
asthma [9]. Obesity promotes a low-grade chronic 
inflammatory state. Both, cellular and humoral 
immunity are reprogrammed to function under 
excessive body weight [10]. The number of leucocytes 
and lymphocytes correlates with the degree of 
obesity, as well as with the monocyte/macrophage 
ratio. They secrete a large number of inflammatory 
cytokines such as tumour necrotic factor-alpha (TNF-
α), interleukin-6 (IL-6), plasminogen activator (PAI-1), 
macrophage chemotactic protein (MCP-1). 
Moreover, an increase in the level of acute-
phase inflammatory reactants such as C-reactive 
protein (CRP), fibrinogen, and complement 
components, especially in abdominal obesity can be 
observed [11], [12]. On the other hand, mediators 
contribute to increased IgE production, subepithelial 
fibrosis, and remodelling of the bronchial trunk, which 
is the primary observation in the pathogenesis of 
asthma [13]. Adipocytes also produce numerous 
hormones, such as leptin and adiponectin, which can 
affect the respiratory system directly, because of the 
expression of leptin receptors in the lung [14] or 
through the cells of the immune system [15]. Atopy is 
an important factor in the development of childhood 
asthma, present in over 80% of children with asthma. 
Most of the studies, however, suggest that 
inflammation of the airway in obese asthmatic adults 
is non-eosinophilic, with significant neutrophilia in the 
induced sputum [16]. 
In this study we sought to investigate the 
association between asthma and obesity in children 
and to establish some of the potential underlying 
mechanisms with particular emphasis on the 
parameters of systemic inflammation (CRP, 
fibrinogen) and the mechanical effect of adipose 
tissue upon the respiratory system through the 
parameters of the lung function as well as to explore 
the role of atopy in overweight children with asthma 
and the type of respiratory inflammation. 
 
 
Material and Methods 
 
The study has been approved by The Ethics 
Committee at the Medical Faculty in Skopje. Written 
informed consent for inclusion in the study was 
obtained by the parents. The study was a prospective 
cross-sectional and included 72 children aged 7-15 
years (11.08 ± 2.23), treated as outpatients or 
inpatients at the University Children's Clinic, Skopje, 
from March to October 2018. Patients were divided 
into three groups: Group 1 consisted of 38 children 
with a high body mass index (BMI); Group 2 consisted 
of 16 children with asthma and a normal BMI; Group 3 
consisted of 18 patients with asthma and high BMI. 
Exclusion criteria included other respiratory, 
gastrointestinal, urogenital, and cardiovascular 
diseases, as well as obesity-associated with other 
than asthma disease or syndrome, and administration 
of systemic corticosteroid therapy three months before 
being included in the study. Medical history was taken 
from the parents and included questions about the 
familial history of diabetes mellitus and atopy, 
premature birth, breastfeeding in the first year of life 
and passive exposure to cigarette smoke at home. 
Each patient underwent through clinical check-up 
including auxology measurements. The following 
laboratory analyses were performed in each child: 
blood counts for eosinophils, systemic inflammatory 
markers (fibrinogen, CRP), and total serum IgE. 
BMI was calculated by a standard formula 
and expressed as a weight (kg)/height(m)
2
. The 
International cut-off points for BMI for overweight and 
obesity by sex between 2 and 18 years, defined to 
pass through a BMI of 25 kg/m
2
 for overweight and 30 
kg/m
2
 for obesity at age 18, were used [17]. For 
abdominal obesity assessment, the waist 
circumference (WC) was measured in centimetres 
between the lower border of the ribcage and midline 
of the iliac crest, as well as the hip circumference 
(HC) in centimetres from the widest point of the hips, 
and then the waist-hip ratio (WHR) was calculated as 
previously described [18]. Reference values were 
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used by sex and age, defined above the 90th 
percentile for abdominal obesity [19]. 
Skin prick test (SP) was performed using 
commercial inhalant allergen extracts, i.e. a mixture of 
grass pollen, a mixture of trees pollen, 
Dermatophagoides pteronyssinus, Dermatophagoides 
farinae, cat epithelium, dog epithelium, mould, and 
cockroach. The test was performed at the volar side of 
the forearm where drops of commercial allergen 
extract Allergopharma (Reinbek, Germany) were 
gently pricked on the skin surface with a separate 
lancet. The distance between drops was not less than 
2 cm. One mg/ml of histamine or saline were used as 
positive or negative control solutions. The test was 
interpreted 15 minutes after the administration of 
allergen extracts, in comparison with the histamine 
and the saline reaction. Atopy was defined as a 
positive response to 1 or more inhalant allergens [20]. 
The assessment of pulmonary function was 
performed with the spirometer Schiller SP-1 [21], [22]. 
Spirometric parameters FEV1, FVC, FEV1/FVC ratio 
or Tiffeneau index, peak expiratory flow (PEF), and 
forced expiratory flows in 25%, 50%, 75% of FVC 
(FEF25, FEF50, FEF75) were assessed. The results 
were expressed in per cent of predictive value for 
gender and age [23]. Spirometric measurements were 
repeated 15 minutes after administration of 200 mcg 
of salbutamol (albuterol) through a metered-dose 
inhaler and a Volumatic spacer device. An increase in 
FEV1 of 12% over baseline was considered as a 
significant bronchodilator response. 
The assessment of eosinophilic airway 
inflammation was carried out by measuring fractional 
exhaled nitric oxide-Fe (NO) using NO analyser Niox 
Vero (Upsala, Sweden). After maximum inspiration, 
the patients exhaled air without prior retention at a 
speed of 50 m/s. Values < 20 ppb in childhood 
indicated non-eosinophilic airway inflammation, or a 
stable clinical condition [24]. 
 
 Statistical Analyses 
Data was statistically analysed in SPSS 
software package, version 22.0 for Windows (SPSS, 
Chicago, IL, USA). The qualitative series were 
processed by determining the coefficient of relations, 
proportions, and rates, and were shown as absolute 
and relative numbers. Quantitative series were 
analysed with measures of central tendency (average, 
median), as well as with dispersion measures 
(standard deviation, standard error).  
The distribution of frequencies was analysed 
through the Shapiro-Wilk test. Pearson Chi-square 
test, Yates corrected, Fischer exact test, and Fisher 
Freeman Halton exact test was used to determine the 
association between certain attributive dichotomies. 
To test the significance of the difference between 
certain analysed numerical parameters, depending on 
the frequency distribution, Student's t-test, One Way 
ANOVA test, Mann Whitney U test and the Kruskal-
Wallis H test were conducted. A two-sided analysis 
with a significance level of p < 0.05 was used to 
determine the statistical significance. 
 
 
Results 
 
The survey included a total of 72 children. 
According to the clinical diagnosis, 38 (52.8%) were 
overweight/obese without asthma, 16 (22.2%) were 
asthmatic with normal BMI, and 18 children (25%) 
were overweight/obese suffering from asthma. The 
average age of the children in the three groups was 
11.4 ± 2.1, 11.0 ± 2.4 and 10.9 ± 2.1 years, 
respectively without a significant difference between 
the groups (p = 0.835).  
Children with asthma in both groups, in the 
group with normal BMI and high BMI, had a 
significantly higher frequency of familial atopy 
compared to the group with high BMI without asthma 
(p = 0.034). There was no significant association 
between the groups regarding sex (p = 0.859), the 
familial history of diabetes mellitus (p = 0.139), 
premature birth (p = 0.111), breastfeeding in the first 
year of life (p = 0.769) and passive exposure to 
cigarette smoke at home (p = 0.265), (Table 1). 
Table 1: Demographic characteristics of the patients  
Parameters Groups of children according to the clinical 
diagnosis 
P 
Overweight/ 
obesity 
N = 38 
Asthma 
N = 16 
Overweight/ 
obesity and 
asthma 
N = 18 
Sex (male) 27 (71.05%) 12 (75%) 14 (77.78%) ** p = 0.859 
Age 11.37 ± 2.19 11.00 ± 2.42 10.89 ± 2.09 ***X
2 
(2) = 0.359; p = 
0.835 
Fam. atopy  19 (50%) 13 (81.25%) 14 (77.78%) ** p = 0.0338* 
Fam. history of 
diabetes 
15 (39.47%) 2 (12.50%) 5 (27.78%) ** p = 0.139 
Premature birth 9 (23.68%) 1 (6.25%) 1 (5.56%) **p = 0.111 
Smokers at home 27 (71.05%) 9 (56.25%) 9 (50%) † 2.652; df = 2; p = 
0.265 
Breastfeeding 
period  
non breastfed 
> 1 ≤ 4 months 
> 4 ≤ 6 months 
> 6 ≤ 12 months 
 
4 (10.53%) 
2 (5.25%) 
10 (26.32%) 
22 (57.89%) 
 
2 (12.5%) 
0 (0%) 
2 (12.5%) 
12.75%) 
 
1 (5.56%) 
0 (%) 
3 (16.67%) 
14 (77.78%) 
 
** p = 0.769 
 
* p < 0.05; ** Fisher Freeman Halton exact test; *** Kruskal-Wallis H test; †Pearson Chi-
square. 
 
There was a significant difference between 
the patients from the three groups regarding the 
average value of the following non-specific 
inflammatory markers: a) eosinophilia-elevated values 
above normal (> 4%) were detected in children with 
asthma both with normal and with high BMI compared 
to the overweight children without asthma (p = 0.001); 
b) CRP values were higher in the overweight groups 
(p = 0.004); c) fibrinogen levels were higher in the 
overweight groups (p = 0.001); d) IgE levels were 
higher in the patients with asthma (p = 0.001), (Table 
2). 
 
Cvejoska-Cholakovska et al. The Association between Asthma and Obesity in Children – Inflammatory and Mechanical Factors 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2019 Apr 30; 7(8):1314-1319.                                                                                                                                                   1317 
 
Table 2: Analysis of non-specific inflammatory markers and 
other parameters analysed according to the clinical diagnosis 
Parameters Groups of children according to the clinical diagnosis P 
Overweight/obe
sity n = 38 
Asthma n = 16 Overweight/obesi
ty and asthma n 
= 18 
WBC 8.52 ± 2.32 7.31 ± 1.98 8.25 ± 2.02 ** 
2 
(2) = 3.955; p 
= 0.138 
Eo 2.60 ± 2.35 6.46 ± 4.77 5.75 ± 2.79 ** 
 2 
(2) = 17.992; 
p < 0.001* 
CRP 3.92 ± 3.54 1.47 ± 2.56 3.93 ± 6.31 ** 
 2 
(2) = 11.304; 
p = 0.004* 
Fibrinogen 3.04 ± 0.46 2.52 ± 0.40 2.78 ± 0.41 *** F = 8.357; p = 
0.001* 
IgE 119.75 ± 189.11 374.02 ± 
494.97 
380.17 ± 333.39 ** 
 2 
(2) = 19.566; 
p < 0.001* 
FEV1 103.79 ± 10.59 97.21 ± 10.74 102.21 ± 12.36 ** 
 2 
(2) = 3.221; p 
= 0.120 
FVC 98.74 ± 9.89 95.99 ± 8.59 99.52 ± 8.47 *** F = 0.6735; p = 
0.513 
FEV1/FVC 99.01 ± 7.89 95.90 ± 8.92 96.47 ± 6.73 ** 
 2 
(2) = 3.191; p 
= 0.203 
PEF 85.24 ± 11.79 87.82 ± 27.28 82.18 ± 14.18 ** 
 2 
(2) = 2.942; p 
= 0.230 
FEF25 81.26 ± 22.41 71.04 ± 27.06 73.69 ± 21.38 *** F = 1.298; p = 
0.280 
FEV50 49.13 ± 13.99 55.76 ± 15.73 49.31 ± 17.02 *** F = 1.163; p = 
0.319 
FEV75 94.72 ± 17.14 81.74 ± 21.64 87.18 ± 17.73 ** 
 2 
(2) = 8.172; p 
= 0.017* 
FeNO (>20 
ppb) 
15.59 ± 9.93 43.83 ± 29.27 39.07 ± 25.01 ** 
 2 
(2) = 16.738; 
p < 0.001* 
BMI  30.38 ± 5.57 18.59 ± 2.01 28.83 ± 5.24 *** F = 33.249; p < 
0.001* 
WC 95.75 ± 19.69 39.06 ± 31.39 90.61 ± 11.09 **
 2 
(2) = 36.427; 
p < 0.001* 
WHR 0.94 ± 0.10 0.86 ± 0.07 0.94 ± 0.12 ** 
 2 
(2) = 4.278; p 
= 0.118 
SPT (positive) 4 (10.53%) 13 (81.25%) 16 (88.89%) Yates correcting = 
41.768; df = 4; p = 
0.000001** 
Bronchodilator 
test (positive) 
7 (18.92%) 14 (87.50%) 16 (100%) / 
FeNo = fractional exhaled nitric oxide; BMI = body mass index; WC = waist circumference; 
WHR = waist-hip ratio; * p < 0.05; ** Kruskal-Wallis H test; *** One Way ANOVA test.  
 
Regarding the spirometric parameters, there 
was a significance only about FEV75, which was the 
lowest in the asthma group (p = 0.017). Regarding all 
other parameters, there was no significant difference 
between the three examined groups. High FeNO 
values had the children from the asthma groups (p = 
0.001). There was a significant association between 
the parameter of personal atopy-SPT and asthma 
diagnosis (p = 0.001). Positive bronchodilator test was 
detected in 14 children with asthma (87.50%), in 18 
children (100%) in an overweight/obese group with 
asthma, and 7 children (18.92%) in the group with 
high BMI. 
 
 
Discussion 
 
The positive association between asthma and 
obesity has been reported in many studies. Recently, 
a meta-analysis related to the BMI and asthma 
association has been published, which has confirmed 
that being overweight or obese increase the risk of 
asthma by 1.64 and 1.92, respectively [25]. Most of 
the studies included in this meta-analysis have 
supported a female-specific association. However, 
others have suggested no gender difference [12]. In 
our study, there was no significant difference 
regarding gender distribution between the groups. 
Children with high BMI have been found to 
have elevated values of the acute-phase inflammation 
reactants, CRP and fibrinogen, not depending on 
asthma. Most studies have reported an elevated CRP 
level in obese children and adults [15], [16].
 
Visser et 
al., have pointed out that CRP increases with BMI. 
Regarding the level of fibrinogen, published studies 
are inconsistent [26]. Canöz and Hafez have 
determined an elevated level of fibrinogen in 
overweight subjects, especially in the presence of 
abdominal obesity [16], [27]. Buyukozturk has not 
established a correlation between obesity, asthma, 
and fibrinogen level [28]. In our study, there was no 
difference between asthmatic children with normal or 
high BMI regarding eosinophilia, total IgE antibodies, 
and positive SPT. For these markers, significantly 
higher values were found in asthma groups compared 
to the overweight/obese group. 
Additionally, asthma groups had significantly 
higher FeNO values and greater occurrence of familial 
atopy, which all support the eosinophilic allergic basis 
of asthma, most common in childhood. FeNO is 
considered as a marker of eosinophilic airway 
inflammation. Thus it is high in atopic asthma. On the 
other hand, asthma in obese adults is usually non-
allergic, with neutrophilia in induced sputum [20]. The 
results of this study support the positive association 
between asthma and obesity with inflammation as a 
common underlying mechanism, eosinophilic one in 
asthma and non-eosinophilic one in obesity. Atopy 
was not established as an underlying mechanism. 
Contrary to our results, Rastogi has not established 
systemic and airway inflammation in overweight 
children with asthma, investigating FeNO, eosinophils 
in induced sputum, CRP, and IL-6 [29]. 
In addition to BMI in the assessment of 
overweight and obesity, some authors like Appleton 
and Kronander have included other parameters, such 
as WC, which better correlates with abdominal obesity 
in children with asthma [30], [31]. Bustos et al., have 
confirmed the association between asthma and BMI, 
but not regarding WC. We assessed the nutritional 
status by examining BMI, WC, and WHR in the three 
study groups and found a positive association of the 
overweight/obese groups either with BMI or with WC. 
Abdominal fat and visceral fatty tissue are considered 
the main source of inflammatory markers that makes 
obesity a "pro-inflammatory condition" [32]. 
Given the goal of our study to examine the 
mechanical effect of obesity on lung function, the 
children with asthma were stable with normal lung 
function, i.e. not in the stage of exacerbation when the 
functional parameters would have been reduced. 
Additionally, all patients with asthma received anti-
inflammatory therapy with inhaled corticosteroids. 
Although the values of the investigated pulmonary 
functional parameters were within the limits of the 
reference among all three groups of children, we did 
not find a significant difference in the mean values 
between them. Only a significantly lower FEV75 value 
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was found in the group of children with asthma, which 
is a parameter for estimating the airflow in the small 
airways. This is understandable because asthma is a 
chronic inflammatory disease predominantly affecting 
small airways. In obesity, due to increased intra-
abdominal pressure by adipose tissue on the 
diaphragm, a pressure on lung and chest is also 
increased, reducing its elasticity and thus leading to a 
decrease in residual volume (RV) and forced 
respiratory capacity (FRC). A large longitudinal study 
involving children and adults with asthma has reported 
a significant reduction in FVC in obese adults but not 
in children [33]. In children with BMI above 85th 
percentile, a significant reduction in FEV1/FVC ratio 
has been demonstrated [34]. However, there are 
some published studies in overweight children with 
asthma that have reported normal static volumes, but 
poor control of asthma due to the impaired perception 
of dyspnoea, which also occurs because of reduced 
elasticity of the chest [35], [36]. The absence of a 
significant difference in pulmonary function 
parameters between asthmatic children and 
overweight children might be in favour of the influence 
of mechanical factors in their association. 
Bronchial hyperreactivity (BHR), a major 
feature of asthma, was tested with a bronchodilator 
test which was positive in over 87% of the asthma 
groups, but also 26% of the overweight children. 
There are studies suggesting BHR in obese adults, 
although they do not include children. Due to obesity, 
the lumen of the airway is reduced, which leads to 
disturbed function of the smooth muscle and over time 
leads to bronchospasm and BHR [37]. Another study 
has suggested that there was no difference in BHR, 
by bronchoprovocation test, between asthmatic 
overweight children and children with normal BMI [38]. 
Van Leeuwen et al. have confirmed that after weight 
reduction in children with asthma, the severity of 
exercise-induced airflow obstruction decreased and 
the quality of life improved [39]. 
The present study has some limitations. The 
number of children in the three examined groups was 
not similar in the time of the analyses, where the 
group composed of overweight patients was larger 
than the other two groups. Additionally, to avoid bias 
because of the small sample, obese patients were 
included in the overweight group.  
A positive association between asthma and 
obesity with inflammation as an underlying 
mechanism was identified, eosinophilic inflammation 
in asthmatic patients and non-eosinophilic 
inflammation in overweight patients. It appears that 
the parameters of lung function did not differ in 
asthma and obesity. The role of atopy in the 
association between asthma and obesity was not 
established. Further investigations are required, 
including specific inflammatory markers for a more 
detailed clarification of the underlying mechanisms. 
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